“…Among these studies, the majority (38/67, 57%) only investigated correlations with a single coarse clinical measure, such as Expanded Disability Status Scale (EDSS), Japanese Orthopedic Association (JOA), modified JOA (mJOA), amyotrophic lateral sclerosis (ALS) Functional Rating Scale (ALSFRS), or ASIA Impairment Scale (AIS), rather than employing a battery of assessments or using more detailed measures of impairment such as ASIA motor/sensory scores. The majority of DTI studies reporting biomarker utility results focused on the metric FA, which was particularly successful in CSM with significant results in 5/5 studies correlating with JOA or mJOA (Spearman r = 0.48–0.88, Pearson R = 0.57–0.64) ( Ellingson et al, 2014 , Gao et al, 2013 , Jones et al, 2013 , Maki et al, 2015 , Wen et al, 2014b ) and in SCI in 4/4 studies correlating with ASIA motor/sensory scores (r = 0.59–0.74, R = 0.78–0.92) ( Cheran et al, 2011 , Cohen-Adad et al, 2011 , Koskinen et al, 2013 , Vedantam et al, 2015 ), but slightly less successful in MS with significant results in only 7/15 studies correlating with EDSS (r = − 0.37–0.51, R = − 0.60) ( Agosta et al, 2007a , Benedetti et al, 2010 , Naismith et al, 2013 , Oh et al, 2013a , Oh et al, 2013b , Toosy et al, 2014 , Valsasina et al, 2005 ), with negative results in 8 studies ( Agosta et al, 2005 , Ciccarelli et al, 2007 , Hodel et al, 2013 , Miraldi et al, 2013 , Oh et al, 2015 , Raz et al, 2013 , Rocca et al, 2012 , Ukmar et al, 2012 ). Other metrics had limited success in MS correlating with EDSS, with significant results for MD in 3/13 studies ( Oh et al, 2013a , Oh et al, 2013b , Valsasina et al, 2005 ), RD in 4/8 studies ( Naismith et al, 2013 , Oh et al, 2013a , Oh et al, 2013b , Toosy et al, 2014 ), MTR in 6/15 studies ( Agosta et al, 2007b , Bozzali et al, 1999 , Kearney et al, 2014 , Lycklama et al, 2000 , Oh et al, 2013a , Oh et al, 2013b ), MTCSF in 2/2 studies ( Fatemi et al, 2005 , Zackowski et al, 2009 ), and the ...…”